Verastem Oncology
VSTM
#6555
Rank
NZ$1.45 B
Marketcap
NZ$11.57
Share price
-7.73%
Change (1 day)
-30.20%
Change (1 year)

Verastem Oncology (VSTM) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$0.28 Billion

According to Verastem Oncology 's latest financial reports the company's total liabilities are NZ$0.28 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verastem Oncology - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.32 B41.29%
2024-12-31NZ$0.23 B58.38%
2023-12-31NZ$0.14 B94.53%
2022-12-31NZ$75.06 M142.96%
2021-12-31NZ$30.89 M-42.95%
2020-12-31NZ$54.15 M-73.55%
2019-12-31NZ$0.20 B-10.21%
2018-12-31NZ$0.22 B404.34%
2017-12-31NZ$45.2 M176.34%
2016-12-31NZ$16.35 M5.38%
2015-12-31NZ$15.52 M23.07%
2014-12-31NZ$12.61 M32.63%
2013-12-31NZ$9.51 M218.41%
2012-12-31NZ$2.98 M-36.35%
2011-12-31NZ$4.69 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$211.38 B 73,778.93%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$18.11 B 6,230.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$129.32 B 45,099.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
NZ$26.09 M-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA